SA
Go ProLog In
INNV
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Hold
7 analysts·Limited coverage
43
Score
0 Buy (0%)5 Hold (71%)2 Sell (29%)
Rating Breakdown
Strong Buy
00%
Buy
00%
Hold
571%
Sell
229%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$5.00
-29.8%
Consensus
$8.00
+12.4%
Bull
$8.00
+12.4%
12-Month Target Range7 analysts
$5.00$8.00$8.00
Current $7.12Consensus
Current Price
$7.12
Upside to Consensus
$0.88

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+7.53%
EPS+82.19%
FY2028
Rev+7.57%
EPS+19.90%

Earnings Surprises

Recent Analyst Actions

Feb 8, 2023J.P. Morgan
JP Morgan Maintains Neutral on InnovAge Holding, Raises Price Target to $8
Target:$8.00
+6.7%from $7.50
Nov 23, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on InnovAge Holding, Raises Price Target to $8
Target:$8.00
+17.6%from $6.80
Nov 16, 2022Citigroup
Citigroup Maintains Neutral on InnovAge Holding, Raises Price Target to $8
Target:$8.00
+10.3%from $7.25
Sep 15, 2022Barclays
Barclays Maintains Equal-Weight on InnovAge Holding, Lowers Price Target to $5
Target:$5.00
+1.2%from $4.94
Apr 20, 2022Piper Sandler
Piper Sandler Downgrades InnovAge Holding to Underweight, Raises Price Target to $5
Target:$5.00
-24.1%from $6.59

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance